Point of view · September 22, 2026

Biologicals companies run out of commercial leaders before they run out of product

The products are ready. The channel is willing. The constraint is the small group of leaders who have taken a biological portfolio to market before.

Every year more biological products reach registration. The bottleneck has moved downstream. A biostimulant or biocontrol product does not sell like a conventional chemistry and the commercial leaders who understand that difference are few.

The profile that wins

From our recent key account and market development placements in biologicals, the leaders who succeed share three traits:

  • Agronomic credibility with growers and advisors, earned in the field rather than in a classroom.
  • Real channel relationships with distributors and retail, not just a contact list.
  • The patience to sell a living product with variable performance and the data discipline to prove it.

Why most searches stall

Companies write a specification for a conventional crop protection seller, then wonder why the candidates do not convert. Others ask for ten years of biologicals experience in a category that has only existed at scale for a few. The answer is to map the adjacent population carefully and assess for transferable judgment.

A short, high-conviction shortlist beats a long list of near misses.

On a recent first commercial hire for a European biocontrol company entering the United States, we worked a tightly defined universe of 73 people, presented two candidates and placed one ahead of the spring campaign. If you are building a biologicals team, see how we work in this sector.

Published by Chaseman Global on September 22, 2026. Follow us on LinkedIn.

Brief us on your next critical hire.

A partner will respond within one working day with a view on the market, the approach and the timeline.